CoJourney is a leading CDMO specializing in developing and manufacturing advanced cell and gene therapy products. We provide end-to-end solutions, from process development to clinical and commercial-scale production of plasmids, viral vectors, mRNA, and sgRNA.

Our proprietary Zero-Chrom Platform® revolutionizes plasmid production by eliminating column chromatography, ensuring 90–95% purity, reducing contamination risks, and improving recovery rates. This innovation enhances efficiency, cutting costs by 70% and production time by 60%, while boosting AAV titers across all serotypes.

With a state-of-the-art facility in Hangzhou, China, and a process development center in Philadelphia, PA, CoJourney has supported 40+ clients, including six in Phase I & II clinical trials. Additionally, we have partnered with Azenta to establish a GMP-grade sgRNA manufacturing platform, further strengthening our capabilities in gene therapy manufacturing.